NPPB and coronary artery disorder: The annual incidence rate of MACE was 8.0% among patients with elevated levels of hs-Tnl and BNP at baseline, compared with 3.0% among those without elevated cardiac biomarkers, supporting the utility of hs-Tnl and BNP as prognostic markers for future cardiovascular events in patients with stable CAD.